Teresińska, A.; Fronczak-Jakubczyk, A.; Woźniak, O.; Maciąg, A.; Jezierski, J.; Cicha-Mikołajczyk, A.; Hoffman, P.; Biernacka, E.K.
The Utility of Baseline Characteristics and [123I]MIBG Cardiac Adrenergic System Scintigraphy in Qualifying Patients with Post-Infarction Heart Failure for Implantable Cardioverter-Defibrillator (ICD) Placement. J. Clin. Med. 2024, 13, 6378.
https://doi.org/10.3390/jcm13216378
AMA Style
Teresińska A, Fronczak-Jakubczyk A, Woźniak O, Maciąg A, Jezierski J, Cicha-Mikołajczyk A, Hoffman P, Biernacka EK.
The Utility of Baseline Characteristics and [123I]MIBG Cardiac Adrenergic System Scintigraphy in Qualifying Patients with Post-Infarction Heart Failure for Implantable Cardioverter-Defibrillator (ICD) Placement. Journal of Clinical Medicine. 2024; 13(21):6378.
https://doi.org/10.3390/jcm13216378
Chicago/Turabian Style
Teresińska, Anna, Aneta Fronczak-Jakubczyk, Olgierd Woźniak, Aleksander Maciąg, Jarosław Jezierski, Alicja Cicha-Mikołajczyk, Piotr Hoffman, and Elżbieta Katarzyna Biernacka.
2024. "The Utility of Baseline Characteristics and [123I]MIBG Cardiac Adrenergic System Scintigraphy in Qualifying Patients with Post-Infarction Heart Failure for Implantable Cardioverter-Defibrillator (ICD) Placement" Journal of Clinical Medicine 13, no. 21: 6378.
https://doi.org/10.3390/jcm13216378
APA Style
Teresińska, A., Fronczak-Jakubczyk, A., Woźniak, O., Maciąg, A., Jezierski, J., Cicha-Mikołajczyk, A., Hoffman, P., & Biernacka, E. K.
(2024). The Utility of Baseline Characteristics and [123I]MIBG Cardiac Adrenergic System Scintigraphy in Qualifying Patients with Post-Infarction Heart Failure for Implantable Cardioverter-Defibrillator (ICD) Placement. Journal of Clinical Medicine, 13(21), 6378.
https://doi.org/10.3390/jcm13216378
